151 related articles for article (PubMed ID: 34997921)
1. Base Editing of Human Pluripotent Stem Cells for Modeling Long QT Syndrome.
Wu F; Guo T; Sun L; Li F; Yang X
Stem Cell Rev Rep; 2022 Apr; 18(4):1434-1443. PubMed ID: 34997921
[TBL] [Abstract][Full Text] [Related]
2. Base Editing Mediated Generation of Point Mutations Into Human Pluripotent Stem Cells for Modeling Disease.
Qi T; Wu F; Xie Y; Gao S; Li M; Pu J; Li D; Lan F; Wang Y
Front Cell Dev Biol; 2020; 8():590581. PubMed ID: 33102492
[TBL] [Abstract][Full Text] [Related]
3. Using Ribonucleoprotein-based CRISPR/Cas9 to Edit Single Nucleotide on Human Induced Pluripotent Stem Cells to Model Type 3 Long QT Syndrome (SCN5A
Ge N; Liu M; Li R; Allen NM; Galvin J; Shen S; O'Brien T; Prendiville TW
Stem Cell Rev Rep; 2023 Nov; 19(8):2774-2789. PubMed ID: 37653182
[TBL] [Abstract][Full Text] [Related]
4. Application of human pluripotent stem cells and pluripotent stem cell-derived cellular models for assessing drug toxicity.
Apáti Á; Varga N; Berecz T; Erdei Z; Homolya L; Sarkadi B
Expert Opin Drug Metab Toxicol; 2019 Jan; 15(1):61-75. PubMed ID: 30526128
[No Abstract] [Full Text] [Related]
5. Allele-specific ablation rescues electrophysiological abnormalities in a human iPS cell model of long-QT syndrome with a CALM2 mutation.
Yamamoto Y; Makiyama T; Harita T; Sasaki K; Wuriyanghai Y; Hayano M; Nishiuchi S; Kohjitani H; Hirose S; Chen J; Yokoi F; Ishikawa T; Ohno S; Chonabayashi K; Motomura H; Yoshida Y; Horie M; Makita N; Kimura T
Hum Mol Genet; 2017 May; 26(9):1670-1677. PubMed ID: 28335032
[TBL] [Abstract][Full Text] [Related]
6. Transient inhibition of p53 enhances prime editing and cytosine base-editing efficiencies in human pluripotent stem cells.
Li M; Zhong A; Wu Y; Sidharta M; Beaury M; Zhao X; Studer L; Zhou T
Nat Commun; 2022 Oct; 13(1):6354. PubMed ID: 36302757
[TBL] [Abstract][Full Text] [Related]
7. Development of a novel two-dimensional directed differentiation system for generation of cardiomyocytes from human pluripotent stem cells.
Moon SH; Ban K; Kim C; Kim SS; Byun J; Song MK; Park IH; Yu SP; Yoon YS
Int J Cardiol; 2013 Sep; 168(1):41-52. PubMed ID: 23044428
[TBL] [Abstract][Full Text] [Related]
8. Safe scarless cassette-free selection of genome-edited human pluripotent stem cells using temporary drug resistance.
Kim KT; Park JC; Jang HK; Lee H; Park S; Kim J; Kwon OS; Go YH; Jin Y; Kim W; Lee J; Bae S; Cha HJ
Biomaterials; 2020 Dec; 262():120295. PubMed ID: 32916603
[TBL] [Abstract][Full Text] [Related]
9. BIG-TREE: Base-Edited Isogenic hPSC Line Generation Using a Transient Reporter for Editing Enrichment.
Brookhouser N; Tekel SJ; Standage-Beier K; Nguyen T; Schwarz G; Wang X; Brafman DA
Stem Cell Reports; 2020 Feb; 14(2):184-191. PubMed ID: 32004495
[TBL] [Abstract][Full Text] [Related]
10. Methods for Automated Single Cell Isolation and Sub-Cloning of Human Pluripotent Stem Cells.
Vallone VF; Telugu NS; Fischer I; Miller D; Schommer S; Diecke S; Stachelscheid H
Curr Protoc Stem Cell Biol; 2020 Dec; 55(1):e123. PubMed ID: 32956572
[TBL] [Abstract][Full Text] [Related]
11. Modeling long QT syndromes using induced pluripotent stem cells: current progress and future challenges.
Friedrichs S; Malan D; Sasse P
Trends Cardiovasc Med; 2013 May; 23(4):91-8. PubMed ID: 23266156
[TBL] [Abstract][Full Text] [Related]
12. Toward Personalized Medicine: Using Cardiomyocytes Differentiated From Urine-Derived Pluripotent Stem Cells to Recapitulate Electrophysiological Characteristics of Type 2 Long QT Syndrome.
Jouni M; Si-Tayeb K; Es-Salah-Lamoureux Z; Latypova X; Champon B; Caillaud A; Rungoat A; Charpentier F; Loussouarn G; Baró I; Zibara K; Lemarchand P; Gaborit N
J Am Heart Assoc; 2015 Sep; 4(9):e002159. PubMed ID: 26330336
[TBL] [Abstract][Full Text] [Related]
13. Generation and purification of human stem cell-derived cardiomyocytes.
Schwach V; Passier R
Differentiation; 2016; 91(4-5):126-38. PubMed ID: 26915912
[TBL] [Abstract][Full Text] [Related]
14. Lessons from the heart: mirroring electrophysiological characteristics during cardiac development to in vitro differentiation of stem cell derived cardiomyocytes.
van den Heuvel NH; van Veen TA; Lim B; Jonsson MK
J Mol Cell Cardiol; 2014 Feb; 67():12-25. PubMed ID: 24370890
[TBL] [Abstract][Full Text] [Related]
15. Myocardial commitment from human pluripotent stem cells: Rapid production of human heart grafts.
Garreta E; de Oñate L; Fernández-Santos ME; Oria R; Tarantino C; Climent AM; Marco A; Samitier M; Martínez E; Valls-Margarit M; Matesanz R; Taylor DA; Fernández-Avilés F; Izpisua Belmonte JC; Montserrat N
Biomaterials; 2016 Aug; 98():64-78. PubMed ID: 27179434
[TBL] [Abstract][Full Text] [Related]
16. Gene editing with 'pencil' rather than 'scissors' in human pluripotent stem cells.
Park JC; Park MJ; Lee SY; Kim D; Kim KT; Jang HK; Cha HJ
Stem Cell Res Ther; 2023 Jun; 14(1):164. PubMed ID: 37340491
[TBL] [Abstract][Full Text] [Related]
17. Allele-specific RNA interference rescues the long-QT syndrome phenotype in human-induced pluripotency stem cell cardiomyocytes.
Matsa E; Dixon JE; Medway C; Georgiou O; Patel MJ; Morgan K; Kemp PJ; Staniforth A; Mellor I; Denning C
Eur Heart J; 2014 Apr; 35(16):1078-87. PubMed ID: 23470493
[TBL] [Abstract][Full Text] [Related]
18. Generating 3D human cardiac constructs from pluripotent stem cells.
Liu C; Feng X; Li G; Gokulnath P; Xiao J
EBioMedicine; 2022 Feb; 76():103813. PubMed ID: 35093634
[TBL] [Abstract][Full Text] [Related]
19. Long QT Syndrome: Genetics and Future Perspective.
Wallace E; Howard L; Liu M; O'Brien T; Ward D; Shen S; Prendiville T
Pediatr Cardiol; 2019 Oct; 40(7):1419-1430. PubMed ID: 31440766
[TBL] [Abstract][Full Text] [Related]
20. The disease-specific phenotype in cardiomyocytes derived from induced pluripotent stem cells of two long QT syndrome type 3 patients.
Fatima A; Kaifeng S; Dittmann S; Xu G; Gupta MK; Linke M; Zechner U; Nguemo F; Milting H; Farr M; Hescheler J; Sarić T
PLoS One; 2013; 8(12):e83005. PubMed ID: 24349418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
